Chargement en cours...
Pharmacokinetic-pharmacodynamic modelling of S(−)-atenolol in rats: reduction of isoprenaline-induced tachycardia as a continuous pharmacodynamic endpoint
BACKGROUND AND PURPOSE: For development of mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) models, continuous recording of drug effects is essential. We therefore explored the use of isoprenaline in the continuous measurement of the cardiovascular effects of antagonists of β-adrenoceptors (β...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Publishing Group
2007
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2013984/ https://ncbi.nlm.nih.gov/pubmed/17420778 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0707234 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|